Watanabe, Takehisa
Hayashi, Sanae
Zhaoyu, Yan
Inada, Hiroki
Nagaoka, Katsuya
Tateyama, Masakuni
Tanaka, Yasuhito http://orcid.org/0000-0002-2473-6966
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP23fk0310518)
Article History
Received: 21 November 2023
Accepted: 17 December 2023
First Online: 5 February 2024
Declarations
:
: Yasuhito Tanaka received Honoraria from AbbVie GK, Gilead Sciences, Inc, Chugai Pharmaceutical Co., Ltd., ASKA Pharmaceutical Holdings Co., Ltd., OTSUKA Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd. and GlaxoSmithKline PLC. He received Research funds from AbbVie GK, FUJIREBIO Inc, Sysmex Corp, Janssen Pharmaceutical K.K., GlaxoSmithKline PLC. and Gilead Sciences, Inc.